Pediatric lung transplant specialist Christian Benden, MD, described the future for children who need lung transplants: fewer ...

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

What is the significance of Path-IO and how could it contribute to clinical care? Immunotherapy has been a transformational ...

Daryl Pritchard, PhD, discusses the challenges to implementing biomarker testing that would advance precision medicine and ...

In lung cancer, surgical resection remains the primary curative treatment, particularly for early-stage Non-Small Cell Lung Cancer (NSCLC). To augment these ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The platform trial will add new arms testing Enhertu in solid tumors with HER2 amplification and gather data on Tafinlar-Mekinist's tissue-agnostic benefit for regular approval.

In combination with atezolizumab, ZEPZELCA has been approved for use in Australia and Singapore as a maintenance treatment for extensive-stage small cell lung cancer (ES-SCLC) in adult patients whose ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors ...

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...